Amphastar Pharmaceuticals - 10 Year Stock Price History | AMPH

Historical daily share price chart and data for Amphastar Pharmaceuticals since 2014 adjusted for splits and dividends. The latest closing stock price for Amphastar Pharmaceuticals as of October 31, 2024 is 50.53.
  • The all-time high Amphastar Pharmaceuticals stock closing price was 65.00 on August 08, 2023.
  • The Amphastar Pharmaceuticals 52-week high stock price is 65.92, which is 30.5% above the current share price.
  • The Amphastar Pharmaceuticals 52-week low stock price is 36.56, which is 27.6% below the current share price.
  • The average Amphastar Pharmaceuticals stock price for the last 52 weeks is 47.61.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Amphastar Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 45.9510 62.2900 63.4500 36.9900 50.5300 -18.30%
2023 46.1088 28.2000 65.0000 27.9900 61.8500 120.74%
2022 31.4325 23.0700 42.2900 22.9600 28.0200 20.31%
2021 19.3787 20.1400 23.2900 17.1100 23.2900 15.81%
2020 18.8403 19.3500 22.4600 12.6600 20.1100 4.25%
2019 20.8106 19.7600 25.2800 17.0700 19.2900 -3.07%
2018 18.4456 19.1700 22.5100 14.6300 19.9000 3.43%
2017 16.6801 18.5000 19.7500 12.2000 19.2400 4.45%
2016 15.9103 13.7000 21.5500 10.5300 18.4200 29.44%
2015 14.2957 11.8400 18.1900 10.7800 14.2300 22.57%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $2.469B $0.644B
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.902B 7.10
Dr Reddy's Laboratories (RDY) India $12.399B 18.57
BridgeBio Pharma (BBIO) United States $4.791B 0.00
Bausch Health Cos (BHC) Canada $3.590B 2.61
Supernus Pharmaceuticals (SUPN) United States $1.872B 377.44
Taysha Gene Therapies (TSHA) United States $0.314B 51.00
Personalis (PSNL) United States $0.270B 0.00
Assembly Biosciences (ASMB) United States $0.107B 0.00
Sol-Gel Technologies (SLGL) Israel $0.014B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00